Not applicableStudy completedNCT01935739What this trial is testingDiscordant HER2/Neu Status of Breast Cancer.Who this might be right forMalignant Neoplasm of Breast. National Cancer Institute, Thailand 105
Testing effectiveness (Phase 2)WithdrawnNCT02452281What this trial is testingPilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced MelanomaWho this might be right forMelanoma Rabih Said
Not applicableStudy completedNCT06549439What this trial is testingEFLASH for Skin Lesions of Malignant MelanomasWho this might be right forMetastatic Melanoma University of Zurich 7
Early research (Phase 1)Study completedNCT01065467What this trial is testingPanobinostat (LBH589) in Patients With Metastatic MelanomaWho this might be right forMelanomaMalignant Melanoma Dana-Farber Cancer Institute 16
Not applicableNo Longer AvailableNCT04544202What this trial is testingCompassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical ResectionWho this might be right forMelanomaAdjuvant Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00101166What this trial is testingUniversal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaWho this might be right forMelanoma (Skin) H. Lee Moffitt Cancer Center and Research Institute 43
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Testing effectiveness (Phase 2)Ended earlyNCT03246906What this trial is testingComparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more Fred Hutchinson Cancer Center 150
Early research (Phase 1)Looking for participantsNCT06375187What this trial is testingGC203 TIL in Advanced Malignant Solid TumorsWho this might be right forSolid TumorGynecologic CancerBreast Cancer+2 more Shanghai Juncell Therapeutics 18
Not applicableUnknownNCT02022579What this trial is testingDCE-MRI and DWI for Detection and Diagnosis of Breast CancerWho this might be right forBreast CancerBIRADS 3BIRADS 4+1 more American College of Radiology Imaging Network 100
Testing effectiveness (Phase 2)Study completedNCT00509288What this trial is testingPhase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered LymphocytesWho this might be right forMelanomaSkin Cancer National Cancer Institute (NCI) 24
Not applicableUnknownNCT00929318What this trial is testingInfluence of Thyroid Hormones on the Woundhealing ProcessWho this might be right forThyroid NeoplasmsThyroid Carcinoma Hannover Medical School 26
Not applicableStudy completedNCT00723710What this trial is testingEffect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)Who this might be right forMelanoma Merck Sharp & Dohme LLC 299
Large-scale testing (Phase 3)Looking for participantsNCT03418961What this trial is testingS1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityWho this might be right forCardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more SWOG Cancer Research Network 491
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Ended earlyNCT05451849What this trial is testingA Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerWho this might be right forMesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more TCR2 Therapeutics 14
Testing effectiveness (Phase 2)Study completedNCT00755976What this trial is testingSulindac and Epirubicin in Treating Patients With Metastatic Malignant MelanomaWho this might be right forMelanoma (Skin) Cancer Trials Ireland 32
Not applicableStudy completedNCT02192333What this trial is testingSurvivorship Care in Reducing Symptoms in Young Adult Cancer SurvivorsWho this might be right forBreast CarcinomaCancer SurvivorDepression+10 more Fred Hutchinson Cancer Center 390
Not applicableStudy completedNCT00293384What this trial is testingAprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT02272855What this trial is testingCombination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic MelanomaWho this might be right forMalignant Melanoma Takara Bio Inc. 46